Contribution of the immune system to the chemotherapeutic response.
- Published in:
- Seminars in Immunopathology, 2011, v. 33, n. 4, p. 353, doi. 10.1007/s00281-011-0246-z
- By:
- Publication type:
- Article
Works matching IS 18632297 AND DT 2011 AND VI 33 AND IP 4
Results: 7
1
2
Immunomodulatory effects of cyclophosphamide and implementations for vaccine design.
- Published in:
- Seminars in Immunopathology, 2011, v. 33, n. 4, p. 369, doi. 10.1007/s00281-011-0245-0
- By:
- Publication type:
- Article
3
Prognostic significance of autoimmunity during treatment of melanoma with interferon.
- Published in:
- Seminars in Immunopathology, 2011, v. 33, n. 4, p. 385, doi. 10.1007/s00281-011-0247-y
- By:
- Publication type:
- Article
4
HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition.
- Published in:
- Seminars in Immunopathology, 2011, v. 33, n. 4, p. 321, doi. 10.1007/s00281-011-0270-z
- By:
- Publication type:
- Article
5
Anti-cancer immune response mechanisms in neoadjuvant and targeted therapy.
- Published in:
- Seminars in Immunopathology, 2011, v. 33, n. 4, p. 341, doi. 10.1007/s00281-011-0261-0
- By:
- Publication type:
- Article
6
The prognostic impact of anti-cancer immune response: a novel classification of cancer patients.
- Published in:
- Seminars in Immunopathology, 2011, v. 33, n. 4, p. 335, doi. 10.1007/s00281-011-0264-x
- By:
- Publication type:
- Article
7
Prognostic impact of anticancer immune responses: an introduction.
- Published in:
- Seminars in Immunopathology, 2011, v. 33, n. 4, p. 317, doi. 10.1007/s00281-011-0278-4
- By:
- Publication type:
- Article